AHA 2024 - Subodh Verma shares the results of a sub-analysis from the SELECT trial in patients who had a prior history of CABG.
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Prof. Subodh Verma is cardiac surgeon at St. Michael's Hospital and professor at the University of Toronto in Toronto, ON, Canada.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 19 November 2024
Recommended
Details
Presenters
Overview
AHA 2024 - Subodh Verma shares the results of a sub-analysis from the SELECT trial in patients who had a prior history of CABG.
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Prof. Subodh Verma is cardiac surgeon at St. Michael's Hospital and professor at the University of Toronto in Toronto, ON, Canada.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 19 November 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
0.75 credits
<p><span data-contrast="auto" style="list-style-type: disc;" xml:lang="EN-US">Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies</span></p>
MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC</span></p>
Advances in Women's Health
Improving the IUD Experience: Evidence-Based Pain Management Approaches
<p>Improving the IUD Experience: Evidence-Based Pain Management Approaches</p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?